Zobrazeno 1 - 10
of 65
pro vyhledávání: '"De Andrea CE"'
Autor:
Yang A, Alex T. Ritter, Christine Moussion, de Andrea Ce, Zora Modrusan, Shannon J. Turley, Spigel D, Yulei Wang, Markus Brown, Price R, Thomas D. Wu, Darya Y. Orlova, Pechuan-Jorge J, Ira Mellman, Ortiz-Muñoz G, Gomez-Roca C, Sanjeev Mariathasan, Catherine B Carbone, Jonas Doerr, Mantri
SummaryThe immune phenotype of a tumor is a key predictor of its response to immunotherapy1–4. Patients who respond to immune checkpoint blockade generally present with tumors that are infiltrated by activated T cells, a tumor-immune phenotype refe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9a3ef624416623587babbf1a616223e
https://doi.org/10.1101/2021.05.27.445482
https://doi.org/10.1101/2021.05.27.445482
Autor:
Waaijer CJ, de Andrea CE, Hamilton A, van Oosterwijk JG, Stringer SE, Bovée JV, Waaijer, Cathelijn J F, de Andrea, Carlos E, Hamilton, Andrew, van Oosterwijk, Jolieke G, Stringer, Sally E, Bovée, Judith V M G
Publikováno v:
Virchows Archiv: European Journal of Pathology; Oct2012, Vol. 461 Issue 4, p475-481, 7p
Autor:
de Andrea CE, Wiweger MI, Bovée JV, Romeo S, Hogendoorn PC, de Andrea, Carlos E, Wiweger, Malgorzata I, Bovée, Judith V M G, Romeo, Salvatore, Hogendoorn, Pancras C W
Publikováno v:
Virchows Archiv: European Journal of Pathology; Jan2012, Vol. 460 Issue 1, p95-102, 8p
Autor:
Malapelle, Umberto, Mayo de Las Casas, Clara, Molina Vila, Miguel A, Rosell, Rafael, Savic, Spasenija, Bihl, Michel, Bubendorf, Lukas, Salto Tellez, Manuel, de Biase, Dario, Tallini, Giovanni, Hwang, David H, Sholl, Lynette M, Luthra, Rajyalakshmi, Weynand, Birgit, Vander Borght, Sara, Missiaglia, Edoardo, Bongiovanni, Massimo, Stieber, Daniel, Vielh, Philippe, Schmitt, Fernando, Rappa, Alessandra, Barberis, Massimo, Pepe, Francesco, Pisapia, Pasquale, Serra, Nicola, Vigliar, Elena, Bellevicine, Claudio, Fassan, Matteo, Rugge, Massimo, de Andrea, Carlos E, Lozano, Maria D, Basolo, Fulvio, Fontanini, Gabriella, Nikiforov, Yuri E, Kamel Reid, Suzanne, da Cunha Santos, Gilda, Nikiforova, Marina N, Roy Chowdhuri, Sinchita, Troncone, Giancarlo
Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::809b1350f923652b496d5a51fdd4e3c6
http://hdl.handle.net/11577/3227754
http://hdl.handle.net/11577/3227754
Autor:
Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Garasa S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Sanchez-Gregorio S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Gomis G; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Martinez-Monge R; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Pinci B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Valencia K; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Solid Tumors Program, Center for Applied Medical Research (CIMA), Pamplona, Spain., Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Barbés B; Department of Radiation Physics and Radiation Protection, Clínica Universidad de Navarra, Pamplona, Spain., Bolaños E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Azpilikueta A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., García-Cardosa M; Department of Physics and Applied Mathematics, Universidad de Navarra, Pamplona, Spain., Burguete J; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Physics and Applied Mathematics, Universidad de Navarra, Pamplona, Spain., Eguren-Santamaría I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Medical Oncology, Universidad de Navarra, Pamplona, Spain., Garate-Soraluze E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain., Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Perez-Gracia JL; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Medical Oncology, Universidad de Navarra, Pamplona, Spain., de Andrea CE; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Anatomy, Physiology and Pathology, Universidad de Navarra, Pamplona, Spain., Rodriguez-Ruiz ME; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain., Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4131-4142.
Autor:
Eguren-Santamaria I; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain., Fernández de Piérola E; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain., Camps G; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain., Martín-Muñoz P; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain., Campos M; CIC energiGUNE, Alava, Spain., Cuculescu D; Clinical Trial Unit, Clínica Universidad de Navarra, Pamplona, Spain., Aguilera-Buenosvinos I; Department of Preventive Medicine and Public Health, Universidad de Navarra, Pamplona, Spain., Rodríguez López I; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain., Salido-Vallejo R; Department of Dermatology, Clínica Universidad de Navarra, Pamplona, Spain., Alexandru R; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain.; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., De Andrea CE; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain.; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., Álvarez-Gigli L; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Spain., Berraondo P; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain., Melero I; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain., Sanmamed MF; Immunology and Immunotherapy, Centro de Investigación Médica Aplicada, Pamplona, Spain msanmamed@unav.es.; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra, Paplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Sep 06; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 06.
Autor:
Aguilera-Buenosvinos I; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain., Martínez-González MA; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain.; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.; Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), Madrid, 28029, Spain.; Department of Nutrition, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, 02115, USA., Romanos-Nanclares A; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sánchez-Bayona R; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain.; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, 28041, Spain., de Andrea CE; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.; Department of Pathology, Clinica Universidad de Navarra, Pamplona, Navarra, 31008, Spain.; Centro de Investigación Biomédica en Red, Área de Cáncer, Madrid, 28029, Spain., Domínguez LJ; Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy.; Faculty of Medicine and Surgery, University of Enna 'Kore', Enna, Italy., Toledo E; Universidad de Navarra Departamento de Medicina Preventiva y Salud Pública, Pamplona, 31008, Spain. etoledo@unav.es.; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain. etoledo@unav.es.; Centro de Investigación Biomédica en Red Área de Fisiología de la Obesidad y la Nutrición (CIBEROBN), Madrid, 28029, Spain. etoledo@unav.es.
Publikováno v:
Journal of physiology and biochemistry [J Physiol Biochem] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
de Dios O; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Ramírez-González MA; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Gómez-Soria I; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Segura-Collar B; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Manosalva J; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., Megías D; Advanced Microscopy Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., De Andrea CE; Department of Anatomy, Physiology and Pathology, Universidad de Navarra, Pamplona, Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Fernández-Rubio L; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain., Hernández-Laín A; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Neuropathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sepúlveda-Sánchez JM; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain.; Hospital HM Sanchinarro, Centro Integral Oncologico Clara Campal, Madrid, Spain., Rodriguez-Ruiz ME; Division of Immunology and Immunotherapy, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Navarra, Spain.; Department of Radiation Oncology, Clinica Universidad de Navarra, Pamplona, Navarra, Spain., Pérez-Núñez Á; Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Surgery, Universidad Complutense de Madrid, Facultad de Medicina, Madrid, Spain., Wainwright DA; Department of Neurological Surgery, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA., Gargini R; Neurooncology Unit, Instituto de Investigaciones Biomédicas I+12, Hospital Universitario 12 de Octubre, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.; Department of Anatomical Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Sánchez-Gómez P; Neurooncology Unit, Chronic Disease Deparment (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain ricgargini.imas12@h12o.es psanchezg@isciii.es.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Aug 30; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 30.
Autor:
Lopez Janeiro A; IdiSNA, Pamplona, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain., Miraval Wong E; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain., Jiménez-Sánchez D; Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Ortiz de Solorzano C; Program of Biomedical Engineering, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Lozano MD; IdiSNA, Pamplona, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Teijeira A; IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; CIMA, Immunology and Immunotherpay, Universidad de Navarra, Pamplona, Spain., Schalper KA; Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Melero I; IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; CIMA, Immunology and Immunotherpay, Universidad de Navarra, Pamplona, Spain.; Nuffield Department of Medicine, Oxford University, Oxford, UK., De Andrea CE; IdiSNA, Pamplona, Spain ceandrea@unav.es.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 May 31; Vol. 12 (5). Date of Electronic Publication: 2024 May 31.
Autor:
Tavira B; Laboratory of Translational Oncology, Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Navarra Institute for Health Research (IdISNA), Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain., Iscar T; Department of Pathology, Cancer Center Clínica Universidad de Navarra, Madrid, Spain., Manso L; Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain., Santaballa A; Department of Medical Oncology, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Gil-Martin M; Department of Medical Oncology, Institut Català d'Oncologia L'Hospitalet, Hospitalet de Llobregat, Spain., García García Y; Department of Medical Oncology, Parc Taulí Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain., Romeo M; Department of Medical Oncology, Institut Català d'Oncologia Badalona, Badalona, Spain., Iglesias M; Department of Medical Oncology, Hospital Son Llátzer, Palma de Mallorca, Spain., de Juan Ferré A; Department of Medical Oncology, Hospital Marqués de Valdecilla, Santander, Spain., Barretina-Ginesta MP; Department of Medical Oncology, Institut Català d'Oncologia Girona, Girona, Spain., Manzano A; Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain., Gaba L; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain., Rubio MJ; Department of Medical Oncology, Hospital Universitario Reina Sofía, Cordoba, Spain., de Andrea CE; Department of Pathology, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., González-Martín A; Laboratory of Translational Oncology, Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Department of Medical Oncology, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 05; Vol. 30 (1), pp. 176-186.